Search alternatives:
significantly improves » significantly improved (Expand Search), significantly improve (Expand Search), significantly improving (Expand Search)
improves decrease » improves disease (Expand Search), improve disease (Expand Search), improved urease (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
Showing 1 - 20 results of 6,817 for search '(( significantly improves decrease ) OR ( significant ((side decrease) OR (greater decrease)) ))', query time: 0.40s Refine Results
  1. 1
    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side.

    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 2
    Summary of significant treatment × time effect.

    Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

    Published 2024
    Save to List
    Saved in:
  3. 3
    Summary of significant single-arm time effect.

    Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

    Published 2024
    Save to List
    Saved in:
  4. 4
    Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side.

    Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups.

    Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Brain regions with significantly decreased activations for the Raven task are shown in blue.

    Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

    Published 2025
    “…Additionally, the plots on the right side display the average plaque count across the cohorts. …”
    Save to List
    Saved in:
  8. 8
    Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before March 31, 2021. Median values with IQR and p-values for significance difference in the medians are provided.

    Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before Marc... by Fatih Gezer (21485468)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Test soil parameters.

    Test soil parameters. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Influence of UHMWPE length on swelling pressure.

    Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    UHMWPF parameters.

    UHMWPF parameters. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Influence of UHMWPE content on swelling pressure.

    Influence of UHMWPE content on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Soil partice-size distribution.

    Soil partice-size distribution. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Analysis of Significantly Different Bacteria.

    Analysis of Significantly Different Bacteria. by Xu Jia (187142)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n 

    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Weekly resistance training frequency over time for the DHA and placebo groups combined (n 

    Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), randomized controlled trial (RCT).

    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: